Singapore to develop and produce new mRNA vaccines

Health Minister Ong Ye Kung said the capability of developing and producing mRNA vaccines will help in Singapore’s pandemic preparedness.

Listen Summarise Singapore aims to develop and produce new mRNA influenza vaccines to boost pandemic preparedness and vaccine manufacturing capabilities, says Health Minister Ong Ye Kung. Singapore supports global vaccine efforts through partnerships with Hilleman Laboratories and major pharmaceutical companies, and plans for an RNA Readiness and Response global biofoundry. The nation focuses on flexible, fast vaccine production platforms and international collaboration to ensure readiness for future pandemics, with continuous-flow manufacturing for large-scale mRNA vaccine output. AI generated

SINGAPORE – Singapore is looking at supporting the development and production of new mRNA influenza vaccines here. This will greatly boost the nation’s pandemic preparedness and is key to helping it exit the next deadly contagion, said Health Minister Ong Ye Kung.